Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
D000917:Antibody Formation / Q000187:drug effects; D001215:Asparaginase / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001216:Asparagine / Q000378:metabolism; D004885:Erwinia / Q000201:enzymology; D004926:Escherichia coli / Q000201:enzymology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008970:Molecular Weight; D011550:Pseudomonas aeruginosa / Q000201:enzymology; D012440:Saccharomyces / Q000201:enzymology
D001216:Asparagine; D001215:Asparaginase